These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 23454741)

  • 1. Molecular determinants of drug-receptor binding kinetics.
    Pan AC; Borhani DW; Dror RO; Shaw DE
    Drug Discov Today; 2013 Jul; 18(13-14):667-73. PubMed ID: 23454741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands.
    Klabunde T
    Br J Pharmacol; 2007 Sep; 152(1):5-7. PubMed ID: 17533415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance.
    Tóth G; Bowers SG; Truong AP; Probst G
    Curr Pharm Des; 2007; 13(34):3476-93. PubMed ID: 18220785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for positive allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2006 Jul; 11(13-14):632-9. PubMed ID: 16793532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal affinity chromatography in characterizing immobilized receptors.
    Calleri E; Temporini C; Massolini G
    J Pharm Biomed Anal; 2011 Apr; 54(5):911-25. PubMed ID: 21190807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery.
    Christopoulos A
    Nat Rev Drug Discov; 2002 Mar; 1(3):198-210. PubMed ID: 12120504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles for modulation of the nuclear receptor superfamily.
    Gronemeyer H; Gustafsson JA; Laudet V
    Nat Rev Drug Discov; 2004 Nov; 3(11):950-64. PubMed ID: 15520817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Target Binding Kinetics in Drug Discovery.
    Guo D; Heitman LH; IJzerman AP
    ChemMedChem; 2015 Nov; 10(11):1793-6. PubMed ID: 26506404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical biology of steroid and nuclear hormone receptors.
    Biggins JB; Koh JT
    Curr Opin Chem Biol; 2007 Feb; 11(1):99-110. PubMed ID: 17188557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship.
    Jyrkkärinne J; Windshügel B; Rönkkö T; Tervo AJ; Küblbeck J; Lahtela-Kakkonen M; Sippl W; Poso A; Honkakoski P
    J Med Chem; 2008 Nov; 51(22):7181-92. PubMed ID: 18983136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors.
    Witt-Enderby PA; Chu GH; Gillen ML; Li PK
    J Med Chem; 1997 Dec; 40(26):4195-8. PubMed ID: 9435890
    [No Abstract]   [Full Text] [Related]  

  • 18. Pocket extraction on proteins via the Voronoi diagram of spheres.
    Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS
    J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-affinity relationships of indole-based melatonin analogs.
    Spadoni G; Mor M; Tarzia G
    Biol Signals Recept; 1999; 8(1-2):15-23. PubMed ID: 10085458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.